| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/03/2009 | US7485649 Inhibitors of checkpoint kinases |
| 02/03/2009 | US7485648 pyridine or pyrimidine thieno(2,3-e)pyrimidine tricyclic compounds; metabotropic glutamate receptor antagonist; analgesic, anxiolytic agent: pain, migraine, urinary incontinence; neurodegenerative diseases: Alzheimer's disease |
| 02/03/2009 | US7485643 Bicyclic inhibitors of MEK and methods of use thereof |
| 02/03/2009 | US7485634 Methods for modulating the activity of receptors are provided. In particular compounds and compositions are provided for modulating the activity of receptors and for the treatment, prevention, or amelioration of one or more symptoms of |
| 02/03/2009 | US7485630 e.g. 2-{[(3'-Amino-1'-aza-2'-oxobicyclo[6.3.0]-undecyl)-11'-carbonyl]amino}-1,5-pentanedioic acid; tripeptide Gly-Pro-Glu (GPE) mimetic; enzymatic degradation, ischemic injury, hypoxic injury, reperfusion injury, and asphyxia |
| 02/03/2009 | US7485285 Delivery of antidepressants through an inhalation route |
| 02/03/2009 | CA2420040C New phenylalanine derivatives |
| 02/03/2009 | CA2382435C Novel herbicidally active phenyl-substituted heterocycles |
| 02/03/2009 | CA2274686C Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 01/30/2009 | CA2712022A1 Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and a pharmaceutical composition comprising it - 026 |
| 01/29/2009 | WO2009014941A1 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors |
| 01/29/2009 | WO2009014679A1 Dolasetron trifluoroacetate, polymorphs of dolasetron trifluoroacetate and process for preparation thereof |
| 01/29/2009 | WO2009014637A2 Heterocyclic amide compounds as protein kinase inhibitors |
| 01/29/2009 | WO2009014217A1 Bicyclic pyrrole derivative |
| 01/29/2009 | WO2009013354A1 ARYLMETHYLENE SUBSTITUTED N-ACYL-β-AMINO ALCOHOLS |
| 01/29/2009 | WO2009013299A2 Novel bradykinin b1 antagonists |
| 01/29/2009 | WO2009013258A1 Use of rylene derivatives as active components in solar cells and photodetectors |
| 01/29/2009 | WO2009012721A1 Process for the preparation of risperidone |
| 01/29/2009 | WO2008142528A3 An improved process for preparing nevirapine |
| 01/29/2009 | WO2008124849A3 Pyrrolo-pyridine kinase modulators |
| 01/29/2009 | WO2007114848A3 Chemical compounds |
| 01/29/2009 | US20090030206 Method for producing quaterrylene-3,4:13, 14-tetracarboxy diimides by direct synthesis |
| 01/29/2009 | US20090030202 Material for organic electroluminescent element and organic electroluminescent element employing the same |
| 01/29/2009 | US20090030030 Arylalkenyl and arylalkynyl substituted imidazoquinolines |
| 01/29/2009 | US20090030029 Novel benzonaphthyridines |
| 01/29/2009 | US20090030027 Androgen Receptor Modulator Compounds and Methods |
| 01/29/2009 | US20090030020 7H-Pyrido[3,4-D]Pyrimidin-8-Ones, Their Manufacture and Use as Protein Kinase Inhibitors |
| 01/29/2009 | US20090030011 1-Aminocarbonyl-, 1-aminosulfoxyl- and 1-aminosulfonyl-substituted triazolopyridines, e.g., 5-chloro-[1,2,3]triazolo[4,5-b]pyridin-1-yl)-(3,4-dihydro-1H-isoquinolin-2-yl)-methanone; these compounds lower triglyceride levels and are used to prevent and treat type II diabetes and arteriosclerosis |
| 01/29/2009 | US20090030010 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents |
| 01/29/2009 | US20090030002 Heterocyclic compounds and their uses |
| 01/29/2009 | US20090029996 Pyridazin-3(2H)-One Derivatives And Their Use As Pde4 Inhibitors |
| 01/29/2009 | US20090029988 Hydroxyalkyl Substituted Imidazoquinolines |
| 01/29/2009 | US20090029987 Pharmaceutical Compositions for the Prevention and Treatment of Complex Diseases and Their Delivery by Insertable Medical Devices |
| 01/29/2009 | US20090029986 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia |
| 01/29/2009 | US20090029980 C-7 Isoxazolinyl Quinolone / Naphthyridine Derivatives Useful as Antibacterial Agents |
| 01/29/2009 | US20090029939 Pre-organized tricyclic integrase inhibitor compounds |
| 01/29/2009 | US20090028855 Inhibitors of akt/pkb with anti-tumor activity |
| 01/29/2009 | DE4497905B4 Verfahren zur Herstellung von Phencynonat-Hydrochlorid mit α-Konfiguration Process for preparing phencynonate hydrochloride with α-configuration |
| 01/29/2009 | DE102007034620A1 Neue B1-Antagonisten New B1 antagonists |
| 01/29/2009 | CA2694251A1 Novel b1-antagonists |
| 01/29/2009 | CA2694224A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 01/29/2009 | CA2693967A1 Heterocyclic amide compounds as protein kinase inhibitors |
| 01/28/2009 | EP2019103A1 Novel compound having affinity for amyloid |
| 01/28/2009 | EP2019094A1 Heterocyclic type cinnamide derivative |
| 01/28/2009 | EP2018859A1 Arylmethylene substituted N-acyl-beta-amino alcohols |
| 01/28/2009 | EP2018167A2 Compositions and methods for fgf receptor kinases inhibitors |
| 01/28/2009 | EP1814880B1 Imidazo[1,2-a]pyridine compounds, compositions, uses and methods related thereto |
| 01/28/2009 | EP1495024B1 Dipyridodiazepinones as reverse transcriptase inhibitors |
| 01/28/2009 | EP1315701B1 Process for the racemisation of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2,3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine |
| 01/28/2009 | EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor |
| 01/28/2009 | CN101356174A Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| 01/28/2009 | CN101356173A Novel pyridopyrazines and their use as modulators of kinases |
| 01/28/2009 | CN101356172A 激酶抑制剂 Kinase inhibitors |
| 01/28/2009 | CN101356171A N4-phenyl-quinaz0line-4-amine derivatives and related compounds as ERBBI type receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
| 01/28/2009 | CN101356161A Heterocyclic CETP inhibitors |
| 01/28/2009 | CN101353349A Perfluoroalkyl chain substituted perylene-3,4:9,10-tetracarboxylic diimide compounds and preparation thereof |
| 01/28/2009 | CN101353348A 7-[4-(aminomethyl)-4-fluoro-3-(alkoxyimine) pyrrolidine-1-yl] substituted quinoline carboxylic acid derivative and preparation thereof |
| 01/28/2009 | CN101353347A Preparation of risperidone |
| 01/28/2009 | CN101353344A Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 01/28/2009 | CN101353320A Matrix metalloprotease inhibitors, medicinal composition containing the same, preparation and use thereof |
| 01/28/2009 | CN100455582C Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 01/28/2009 | CN100455581C Imidazopyridine derivatives as melanocortin receptor agonists. |
| 01/27/2009 | US7482462 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 01/27/2009 | US7482456 8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors |
| 01/27/2009 | US7482454 Antimicrobial quinolones, their compositions, and uses |
| 01/27/2009 | US7482453 dissolving clopidogrel in ethyl acetate solvent then adding sulfuric acid; good yield and purity of enantiomer |
| 01/27/2009 | US7482452 intermediates for p38 MAP kinase inhibitors; industrial scale; 3-cyano-6-oxo-2-thio-1,6-dihydropyridines or pyrimidine, 2,4-diones as starting reactants and 2-cyano-N-phenylthioacetamide; cyclization; diazotization of 3-amino-7H-thieno[2,3-b]pyridin-6-ones, halide displacement |
| 01/27/2009 | US7482373 useful in the treatment of central or peripheral nervous system disorders; psychological disorders; gastrointestinal disorders |
| 01/27/2009 | US7482372 Antiinflammatory; cartilage protecting therapeutics; antiarthritic agent; N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl}-2,4-dioxo-1,3-diazaspiro[4.5]decane-6-carboxamide; 2-(2,5-dioxo-4-imidazolidinyl)-N-{4-[(2-methyl-4-quinolinyl)methoxy]phenyl)acetamide |
| 01/27/2009 | US7482364 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine |
| 01/27/2009 | US7482360 Fused tetracyclic mGluR1 antagonists as therapeutic agents |
| 01/27/2009 | US7482359 Androgen receptor modulators |
| 01/27/2009 | US7482358 2-(5-cyano-3-pyridyl)-4-(4-fluorophenyl)-4-(6-fluoro-3-pyridyl)-5-methyl-2-imidazoline; obesity, bulimia; antidiabetic agents; neuropeptide Y receptor antagonists |
| 01/27/2009 | US7482354 Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 01/27/2009 | US7482350 4,5-disubstituted-2-aryl pyrimidines |
| 01/27/2009 | US7482345 P38 kinase inhibiting agents |
| 01/27/2009 | US7482342 Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors |
| 01/27/2009 | US7482336 Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
| 01/27/2009 | CA2335115C Fused azepinone cyclin dependent kinase inhibitors |
| 01/22/2009 | WO2009012283A1 Compounds and methods for kinase modulation, and indications therefor |
| 01/22/2009 | WO2009011904A1 Compounds useful as faah modulators and uses thereof |
| 01/22/2009 | WO2009011871A2 Thiadiazole modulators of pkb |
| 01/22/2009 | WO2009010988A1 An improved, industrially viable process for the preparation of high purity paliperidone |
| 01/22/2009 | WO2009010801A1 Spiro condensed barbituric acid derivatives for use as antibacterial |
| 01/22/2009 | WO2009010791A2 Cyclic ethers |
| 01/22/2009 | WO2009010530A1 Bicyclic heteroaryl compounds and their use as kinase inhibitors |
| 01/22/2009 | WO2009010491A1 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors |
| 01/22/2009 | WO2009010488A1 Heterocyclic compounds useful as mk2 inhibitors |
| 01/22/2009 | WO2009010129A1 Bispidon ligands and the metal complexes thereof |
| 01/22/2009 | WO2008145842A3 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/22/2009 | WO2008101935A3 New indole derivative compounds and pharmaceutical compositions containing the same |
| 01/22/2009 | WO2008083367A4 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/22/2009 | WO2008055013A3 5-oxo-5,8 - dihydro - pyrido - pyrimidines as inhibitors of c-fms kinase |
| 01/22/2009 | WO2007136465A3 Compositions and methods for fgf receptor kinases inhibitors |
| 01/22/2009 | US20090023770 1-methoxy-2-methyl-3-[(4-nitrophenyl)sulphonyl]indolizine, used as angiogenesis inhibitors |
| 01/22/2009 | US20090023769 Organic Compounds |
| 01/22/2009 | US20090023767 Anticancer agents; initiasting mitosis which causes tumor cell death |
| 01/22/2009 | US20090023763 Condensed Pyridine Derivatives Useful as A2B Adenosine Receptor Antagonists |
| 01/22/2009 | US20090023757 Process for preparing bicyclic compounds |
| 01/22/2009 | US20090023756 Substituted quinazolines as pde10 inhibitors |